首页> 外文期刊>Coronary artery disease >Drug-eluting stents for drug-eluting stent restenosis: stick with the old or switch to a new one?
【24h】

Drug-eluting stents for drug-eluting stent restenosis: stick with the old or switch to a new one?

机译:药物洗脱支架用于再狭窄的药物再狭窄:坚持旧的还是改用新的?

获取原文
获取原文并翻译 | 示例
           

摘要

Progress in the modification of conventional coronary risk factors and lifestyle behavior has reduced the incidence of atherosclerotic coronary artery disease; nonetheless, it continues to be the leading cause of mortality in the world. This might be attributed to the defective risk stratifying and prevention strategy for coronary artery disease. In the current clinical setting, atherosclerotic coronary artery disease risk is estimated on the basis of identifying and quantifying only traditional risk factors; it does not take into consideration nontraditional risk factors. In addition, most of the prevailing therapies for atherosclerosis are targeted toward traditional risk factors rather than atherosclerosis itself. It is desirable to develop a method that can directly assess the activity of atherogenesis at every moment. Endothelial function is an integrated index of all atherogenic and atheroprotective factors present in an individual including nontraditional factors and heretofore unknown factors, and it is reported to have additional predictive value for future cardiovascular events to traditional risk factors. Moreover, endothelial function has a pivotal role in all phases of atherosclerosis, from initiation to atherothrombotic complication, and is reversible at every phase, indicating that endothelial function-guided therapies might be effective and feasible in cardiovascular practice. Thus, the introduction of endothelial function testing into clinical practice might enable us to innovate individualized cardiovascular medicine. In this review, we summarize the current knowledge on the contribution of endothelial dysfunction to atherogenesis and review the methods that assess endothelial function. Finally, we focus on the effects of major antiatherosclerotic disease therapies on endothelial function and argue the possibility of noninvasive assessment of endothelial function aiming at individualized cardiovascular medicine.
机译:改变常规冠状动脉危险因素和生活方式的进展减少了动脉粥样硬化性冠状动脉疾病的发生。尽管如此,它仍然是世界上导致死亡的主要原因。这可能归因于冠状动脉疾病的不良风险分层和预防策略。在目前的临床环境中,仅在识别和量化传统危险因素的基础上估算动脉粥样硬化性冠状动脉疾病的风险。它未考虑非传统风险因素。另外,大多数流行的动脉粥样硬化疗法都针对传统的危险因素,而不是针对动脉粥样硬化本身。期望开发一种可以随时评估动脉粥样硬化活动的方法。内皮功能是个体中所有动脉粥样硬化和动脉粥样硬化保护因素的综合指数,包括非传统因素和迄今未知的因素,据报道它对未来心血管事件具有比传统危险因素更高的预测价值。此外,内皮功能在动脉粥样硬化的所有阶段(从开始到动脉粥样硬化并发症)都具有关键作用,并且在每个阶段都是可逆的,这表明以内皮功能为指导的疗法在心血管实践中可能是有效和可行的。因此,将内皮功能测试引入临床实践可能使我们能够创新个性化的心血管医学。在这篇综述中,我们总结了有关内皮功能障碍对动脉粥样硬化形成的作用的当前知识,并回顾了评估内皮功能的方法。最后,我们着眼于主要的抗动脉粥样硬化疾病疗法对内皮功能的影响,并提出针对个体化心血管医学的无创评估内皮功能的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号